| 000 | 01319 a2200349 4500 | ||
|---|---|---|---|
| 005 | 20250512200401.0 | ||
| 264 | 0 | _c19841101 | |
| 008 | 198411s 0 0 eng d | ||
| 022 | _a0361-5960 | ||
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aNechay, B R | |
| 245 | 0 | 0 |
_aCharacteristics of inhibition of human renal adenosine triphosphatases by cisplatin and chloroplatinic acid. _h[electronic resource] |
| 260 |
_bCancer treatment reports _cSep 1984 |
||
| 300 |
_a1135-41 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 |
_aAdenosine Triphosphatases _xantagonists & inhibitors |
| 650 | 0 | 4 |
_aAscorbic Acid _xpharmacology |
| 650 | 0 | 4 | _aCa(2+) Mg(2+)-ATPase |
| 650 | 0 | 4 |
_aCalcium-Transporting ATPases _xantagonists & inhibitors |
| 650 | 0 | 4 |
_aCisplatin _xantagonists & inhibitors |
| 650 | 0 | 4 |
_aCysteine _xpharmacology |
| 650 | 0 | 4 |
_aGlutathione _xpharmacology |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aIn Vitro Techniques |
| 650 | 0 | 4 |
_aKidney _xdrug effects |
| 650 | 0 | 4 |
_aMethionine _xpharmacology |
| 650 | 0 | 4 |
_aPlatinum _xantagonists & inhibitors |
| 650 | 0 | 4 | _aPlatinum Compounds |
| 650 | 0 | 4 |
_aSodium-Potassium-Exchanging ATPase _xantagonists & inhibitors |
| 700 | 1 | _aNeldon, S L | |
| 773 | 0 |
_tCancer treatment reports _gvol. 68 _gno. 9 _gp. 1135-41 |
|
| 999 |
_c6148210 _d6148210 |
||